Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
PDF vom PMID32408336  :  Publisher

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Proteomics of SARS-CoV-2-infected host cells reveals therapy targets #MMPMID32408336
  • Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Munch C
  • Nature 2020[Jul]; 583 (7816): 469-472 PMID32408336show ga
  • A new coronavirus was recently discovered and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 in humans causes coronavirus disease 2019 (COVID-19) and has been rapidly spreading around the globe(1,2). SARS-CoV-2 shows some similarities to other coronaviruses; however, treatment options and an understanding of how SARS-CoV-2 infects cells are lacking. Here we identify the host cell pathways that are modulated by SARS-CoV-2 and show that inhibition of these pathways prevents viral replication in human cells. We established a human cell-culture model for infection with a clinical isolate of SARS-CoV-2. Using this cell-culture system, we determined the infection profile of SARS-CoV-2 by translatome(3) and proteome proteomics at different times after infection. These analyses revealed that SARS-CoV-2 reshapes central cellular pathways such as translation, splicing, carbon metabolism, protein homeostasis (proteostasis) and nucleic acid metabolism. Small-molecule inhibitors that target these pathways prevented viral replication in cells. Our results reveal the cellular infection profile of SARS-CoV-2 and have enabled the identification of drugs that inhibit viral replication. We anticipate that our results will guide efforts to understand the molecular mechanisms that underlie the modulation of host cells after infection with SARS-CoV-2. Furthermore, our findings provide insights for the development of therapies for the treatment of COVID-19.
  • |*Molecular Targeted Therapy[MESH]
  • |*Proteomics[MESH]
  • |Betacoronavirus/*drug effects/genetics/growth & development/*metabolism[MESH]
  • |COVID-19[MESH]
  • |Caco-2 Cells[MESH]
  • |Carbon/metabolism[MESH]
  • |Coronavirus Infections/*drug therapy/genetics/*metabolism/virology[MESH]
  • |Drug Evaluation, Preclinical[MESH]
  • |Host-Pathogen Interactions/drug effects/genetics[MESH]
  • |Humans[MESH]
  • |In Vitro Techniques[MESH]
  • |Kinetics[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy/genetics/*metabolism/virology[MESH]
  • |Protein Biosynthesis/drug effects[MESH]
  • |Proteome/metabolism[MESH]
  • |Proteostasis[MESH]
  • |RNA Splicing[MESH]
  • |SARS-CoV-2[MESH]
  • |Time Factors[MESH]
  • |Virus Replication/drug effects[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    469 7816.583 2020